Document is current
Any future updates will be listed below
-
Authors
Chan, Calvin
Goadsby, Peter J. https://orcid.org/0000-0003-3260-5904
-
Funding
Funding for this research was provided by:
National Institute for Health Research South London
South London and Maudsley NHS Foundation Trust
Institute of Psychiatry, Psychology and Neuroscience, King’s College London
- License Information
-
More Information
Article History
First Online: 25 September 2019
Compliance with Ethical Standards
:
: This paper represents independent research funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King’s College London, Institute of Psychiatry, Psychology and Neuroscience, King’s College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.
: Calvin Chan has no conflicts of interest to disclose. Peter J. Goadsby reports, over the last 36 months, grants and personal fees from Amgen and Eli-Lilly and Company; personal fees from Alder Biopharmaceuticals, Allergan, Autonomic Technologies Inc., Biohaven Pharmaceuticals Inc., Dr Reddy’s Laboratories, Electrocore LLC, eNeura, Impel Neuropharma, MundiPharma, Novartis, Teva Pharmaceuticals, Trigemina Inc., and W.L. Gore; personal fees from MedicoLegal work, Massachusetts Medical Society, Up-to-Date, Oxford University Press, and Wolters Kluwer; and a patent magnetic stimulation for headache assigned to eNeura without fee.
